FRESENIUS MEDICAL CARE

Fresenius Medical Care offers products and services along the entire dialysis value chain from a single source. As of December 31, 2024, we cared for more than 299,000 patients in our global network of approximately 3,700 dialysis clinics. At the same time, we operated around 40 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables.

Fresenius Medical Care aims to further consolidate its expertise and to use this competence as a basis for sustainable profitable growth. We aim to continuously improve our patients’ quality of life by offering them high-quality products as well as innovative technologies and treatment concepts.

Our worldwide research and development (R&D) activities enable us to develop products and renal therapies efficiently and to systematically promote the global exchange of knowledge and technology.

Health care systems face major financial challenges. We aim to direct our research and development activities towards developing innovative products and renal therapies that not only meet high quality standards that improve clinical outcomes but are also affordable. As an operator of proprietary dialysis clinics and a provider of products for treating patients at home, we believe that these aims are entirely compatible.

Our research and development strategy contributes to our corporate strategy which aims to provide health care for chronically and critically ill patients across the renal care continuum by developing adjacent products and therapies for Extracorporeal Membrane Oxygenation, as well as by acquiring and developing complementary assets. Our globally oriented research and development strategy enables us to respond more effectively to the worldwide rise in demand for high-quality and cost-efficient treatment and therapy methods.